Ligand Pharmaceuticals/ US53220K5048 /
17.05.2024 21:59:34 | Изменение +0.97 | Объем сделки | Бид- | Предложение- | Максимум | Минимум |
---|---|---|---|---|---|---|
85.95USD | +1.14% | 4,588 Оборот: 394,819.56 |
-Величина цены спроса: - | -Величина цены предложения: - | 86.89 | 85.34 |
GlobeNewswire
21:05
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Thera...
GlobeNewswire
20:45
NARI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors ...
GlobeNewswire
18:37
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Xiao-I Corporation Investors to Inquire About ...
GlobeNewswire
18:32
Evolv Technologies (EVLV) Slashes 2024 Revenue Expectations, Class Action Pending - Hagens Berman
GlobeNewswire
18:14
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Equity LifeStyle Properties, Inc. Investors to Inquir...
GlobeNewswire
15:45
Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact ...
GlobeNewswire
15:30
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Co...
GlobeNewswire
15:30
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UnitedHealth
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница